new_adrs_0322_1343|PYXS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_1343|PYXS|1|Pyxis Oncology Inc Total Current Assets (Quarterly) (USD)|Pyxis Oncology Inc Cash and Short Term Investments (Quarterly) (USD)|Pyxis Oncology Inc Inventories (Quarterly) (USD)|Pyxis Oncology Inc Net PP&E (Quarterly) (USD)|Pyxis Oncology Inc Goodwill and Intangibles (Quarterly) (USD)|Pyxis Oncology Inc Total Liabilities (Quarterly) (USD)|Pyxis Oncology Inc Total Current Liabilities (Quarterly) (USD)|Pyxis Oncology Inc Total Long Term Liabilities (Quarterly) (USD)|Pyxis Oncology Inc Total Deposits (Quarterly) (USD)|Pyxis Oncology Inc Book Value (Quarterly) (USD)|Pyxis Oncology Inc Retained Earnings (Quarterly) (USD)|Pyxis Oncology Inc Treasury Stock (Quarterly) (USD)|Pyxis Oncology Inc EV to Revenues|Pyxis Oncology Inc EV to Earnings|Pyxis Oncology Inc EV to Free Cash Flow|Pyxis Oncology Inc EV to Assets (Quarterly)|Pyxis Oncology Inc PS Ratio|Pyxis Oncology Inc PE Ratio|Pyxis Oncology Inc Price to Book Value|Pyxis Oncology Inc PEG Ratio|Pyxis Oncology Inc Debt to Equity Ratio|Pyxis Oncology Inc Dividend Yield|Pyxis Oncology Inc Shareholder Yield (TTM)|Pyxis Oncology Inc Percent of Shares Outstanding Short|Pyxis Oncology Inc Total Receivables (Quarterly) (USD)|Pyxis Oncology Inc Total Payables (Quarterly) (USD)|Pyxis Oncology Inc Total Capital Stock (Quarterly) (USD)|Pyxis Oncology Inc Return on Invested Capital|Pyxis Oncology Inc Quality Ratio Score|Pyxis Oncology Inc Momentum Score|Pyxis Oncology Inc Beta (1Y)|Pyxis Oncology Inc Sustainable Growth Rate (TTM)|Pyxis Oncology Inc Institutional Investor Ownership Percentage|Pyxis Oncology Inc Average Diluted Shares Outstanding (Quarterly)|Pyxis Oncology Inc Total Employees (Annual)|Pyxis Oncology Inc EPS Diluted (Quarterly) (USD)|Pyxis Oncology Inc Shares Outstanding|Pyxis Oncology Inc Repurchase of Capital Stock (Quarterly) (USD)|Pyxis Oncology Inc Ordinary Shares Number (Quarterly)|Pyxis Oncology Inc Payout Ratio|Pyxis Oncology Inc Quick Ratio (Quarterly)|Pyxis Oncology Inc Normalized Diluted EPS (Quarterly) (USD)|Pyxis Oncology Inc Stock Buybacks (Quarterly) (USD)|Pyxis Oncology Inc Effective Tax Rate (TTM)|Pyxis Oncology Inc Return on Equity|Pyxis Oncology Inc Net Income (TTM) (USD)|Pyxis Oncology Inc Revenue (TTM) (USD)|Pyxis Oncology Inc Dividend Per Share (Quarterly) (USD)|Pyxis Oncology Inc Revenue (Quarterly) (USD)|Pyxis Oncology Inc Gross Profit (Quarterly) (USD)|Pyxis Oncology Inc SG&A Expense (Quarterly) (USD)|Pyxis Oncology Inc Pre-Tax Income (Quarterly) (USD)|Pyxis Oncology Inc Net Income (Quarterly) (USD)|Pyxis Oncology Inc Net Interest Income (Quarterly) (USD)|Pyxis Oncology Inc Price (USD)|Pyxis Oncology Inc Total Return Price (USD)|Pyxis Oncology Inc Enterprise Value (USD)|Pyxis Oncology Inc 30-Day Average Daily Volume|Pyxis Oncology Inc 1 Year Price Returns (Daily)||
new_adrs_0322_1343|PYXS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_1343|PYXS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_adrs_0322_1343|PYXS|5|181|181||181||181|181|181||181|181||||1.45045045045|||||||1.45045045045||15.1111111111||181|181||||||30||||||181|||||||181|||||||||1.45045045045|1.45045045045|1.45045045045|1.46341463415|||
new_adrs_0322_1343|PYXS|6|1|1||1||1|1|1||1|1||||111|||||||111||9||1|1||||||4||||||1|||||||1|||||||||111|111|111|82|||
new_adrs_0322_1343|PYXS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_1343|PYXS|202012|8.103|8.08||1.939||25.796|3.689|22.107||-15.645|-15.743|||||||||||||||1.141|0.001||||||||||||30.5741|||||||-12.828|||||||||||||||
new_adrs_0322_1343|PYXS|202106|142.944|142.473||1.854||32.556|8.412|24.144||-57.588|-60.714|||||||||||||||1.266|172.083||||||||||||30.5741|||||||-52.741|||||||||||||||
new_adrs_0322_1343|PYXS|202109|||||||||||||||-19.5568|||||||||2.5983|||||||||12.2002||39||30.5741||||||||||||||||||13.34|13.34|437.4665|143235.9||12.77|
new_adrs_0322_1343|PYXS|202112|||||||||||||||-16.3175|||||||||1.6825|||||||||71.697||||||||||||||||||||||10.97|10.97|365.0059|211077.3333||9.54|6.08
new_adrs_0322_1343|PYXS|202203|||||||||||||||-8.7727||||||||||||||||||||||||||||||||||||||||5.45|5.45|196.2368|47829.8|||